News
The National Institutes of Health revealed its roster of ambitious goals for the next five years and many of them are either focused on reliant upon technologies.
In the ongoing battle at the small end of the electronic health records market, drchrono claims to have struck new ground by bringing its EHR to the iPhone.
Healthcare organizations are bulking up their privacy protections with firewalls, encryption, data loss prevention software and more, but the much lower-tech visual hacking threat is still a concern, according to a new 3M educational campaign.
WellDoc, whose BlueStar technology is focused on adults with Type 2 diabetes, has drawn $22 million in a Series B round of funding from Samsung Ventures and existing investor Merck Global Health Innovation Fund. The company will use the money to continue commercialization and accelerate adoption of BlueStar.
Kaiser Permanente plans to build a medical school in Southern California, the integrated care giant announced on Thursday. The plan is to enroll the first class of 48 students in 2019.
HCA has made a "strategic investment" in Nashville-based cognitive computing developer Digital Reasoning as it works to derive more clinical and financial value from unstructured EHR data, the company said Thursday.
Substantial interoperability has yet to be achieved across healthcare, a recent report to Congress from the Office of the National Coordinator's Health IT Policy Committee shows, held up by reasons including lack of standardization and security concerns.
Jonathan S. Lewin, MD, senior vice president for integrated healthcare delivery and co-chair for strategic planning at Johns Hopkins Medicine, will leave the Baltimore health system for Emory Healthcare in Atlanta. He is slated to begin his tenure as president, CEO and chairman of the board of directors at Emory on Feb. 1.
Three Community Healthcare System hospitals in Indiana have achieved Stage 7, the highest level on HIMSS Analytics' Electronic Medical Record Adoption Model.
Martin Shkreli, the infamous pharma CEO who drew widespread scorn for hiking the price of AIDS drug Daraprim from $13.50 a pill to $750, was arrested by federal agents Thursday morning on charges of securities fraud.